What oral antibiotics are recommended for treating Group B strep (Streptococcus agalactiae) urinary tract infections (UTIs) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Group B Streptococcus UTI in Pregnancy

For Group B streptococcus (GBS) urinary tract infections during pregnancy, penicillin G (5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours) or ampicillin (2 g IV initial dose, then 1 g IV every 4 hours) are the first-line treatments, with oral amoxicillin as an appropriate outpatient option. 1

First-Line Treatment Options

Intravenous Options

  • Penicillin G: 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours
  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours

Oral Options (for outpatient management)

  • Amoxicillin: Standard UTI dosing (typically 500 mg three times daily for 5-7 days)

Treatment Algorithm for Penicillin-Allergic Patients

For patients with non-severe penicillin allergy:

  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours 2, 1

For patients with severe penicillin allergy (history of anaphylaxis, angioedema, respiratory distress, or urticaria):

  1. If susceptibility testing available and isolate is susceptible to both clindamycin and erythromycin:

    • Clindamycin: 900 mg IV every 8 hours 2, 1
  2. If isolate is resistant to erythromycin but susceptible to clindamycin:

    • Use clindamycin only if testing for inducible clindamycin resistance is negative 2, 1
  3. If susceptibility testing unavailable OR isolate resistant to clindamycin OR inducible resistance present:

    • Vancomycin: 1 g IV every 12 hours 2, 1

Important Clinical Considerations

Antimicrobial Resistance

  • GBS remains universally susceptible to penicillin, making it the preferred treatment option 1
  • Resistance to clindamycin (5-21%) and erythromycin (9-29%) has been documented and is increasing 3, 4, 5
  • Susceptibility testing is essential when using alternatives to penicillin 1

Duration of Treatment

  • For uncomplicated UTIs: 5-7 days 1
  • For complicated UTIs or pyelonephritis: 10-14 days 1
  • Continue treatment for at least 48-72 hours after symptoms resolve 1

Follow-Up and Intrapartum Prophylaxis

  • Any colony count of GBS in urine during pregnancy is considered significant and indicates heavy genital tract colonization 1
  • All pregnant women with GBS bacteriuria at any point during pregnancy require intrapartum antibiotic prophylaxis during labor, regardless of previous treatment 1
  • Antibiotics do not eliminate GBS from genitourinary and gastrointestinal tracts, and recolonization after treatment is typical 1

Common Pitfalls to Avoid

  1. Inadequate susceptibility testing: Always perform susceptibility testing for penicillin-allergic patients due to increasing resistance to alternative antibiotics 1

  2. Treating with oral antibiotics alone in severe cases: IV antibiotics may be necessary for pyelonephritis or severe UTI symptoms 1

  3. Failure to provide intrapartum prophylaxis: Even if GBS UTI was treated earlier in pregnancy, intrapartum prophylaxis is still required during labor 2, 1

  4. Using erythromycin: Erythromycin is no longer recommended for GBS prophylaxis due to increasing resistance and poor placental transfer 2, 1

  5. Attempting to eradicate colonization: Treating GBS colonization with oral antibiotics in the third trimester is ineffective, as 30-70% of treated women remain colonized at delivery 1

By following these evidence-based recommendations, clinicians can effectively treat GBS UTI in pregnancy while minimizing risks to both mother and baby.

References

Guideline

Group B Streptococcus Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.